← All diseases Liver, kidneys and digestion

Liver cirrhosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest Quality Evidence Only (112)Meta-analysis (33)Treatment guideline (8)Randomized trial (33)Systematic review (22)Phase 3 study (16)Clinical trial (635)Review article (465)Early study (phase 1 or 2) (8)Laboratory or animal research (168)Case report (153)Commentary or editorial (44)Retracted Publication (4) Studies Currently Seeking Participants Only (38)

Filter

Publications and studies (3127)

• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers (2026-01-13) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy (2026-01-12) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Mechanisms of Malnutrition in Cirrhosis With Portosystemic Shunting (2026-01-09) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or Mutations (2026-01-09) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis (2026-01-08) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Fenofibrate in Primary Biliary Cholangitis: a Real World Study (2026-01-08) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis (2026-01-08) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study (2026-01-08) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study to Determine Pharmacokinetic Changes of Ceftriaxone in Patients With Liver Cirrhosis (2026-01-08) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis (2026-01-08) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis (2026-01-07) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study (2026-01-07) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. STOP HCC-GAAD-APAC-Thailand (2026-01-06) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis (2026-01-06) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. EUS-guided Versus Percutaneous Ultrasound-guided Biopsy for Parenchymal Liver Disease (2026-01-05) ♡
• Sex-specific differences in the prognostic value of METS-IR for long-term outcomes in patients with MASLD and advanced liver fibrosis: a nationwide study. (2025/12/31) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Hepato-Cardio-Renal Axis in Cirrhosis: Hemodynamic and Mechanistic Insights, Diagnostic Biomarkers, and Expanding Therapeutic Horizons. (2025/12/31) ♡
• Identification of secretory protein related biomarkers for primary biliary cholangitis based on machine learning and experimental validation. (2025/12/30) ♡
• Diet-induced steatohepatitis does not cause heart failure with preserved ejection fraction in male middle-aged C57BL/6N mice. (2025/12/29) ♡
• Ultrasound and SWE-based transfer learning for predicting fibrotic NASH. (2025/12/29) ♡
• The Effects of Flaxseed Consumption on Frailty and Sarcopenia in Patients With Liver Cirrhosis: An Open-Labeled Randomized Controlled Clinical Trial. (2025/12/29) ♡
• Low Rates of MASLD Screening in Young Adults With Type 2 Diabetes: A Retrospective Cohort Study. (2025/12/29) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Human Albumin-enriched Peritoneal Dialysis: A Novel Approach to Manage Refractory Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease. (2025/12/28) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Quality and Quantity? The Clinical Significance of Myosteatosis in Various Liver Diseases: A Narrative Review. (2025/12/28) ♡
• MAFLD increases CKM syndrome severity: a NHANES-based cross-sectional study. (2025/12/26) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Diagnostic Performance of LIVERFASt as a Non-invasive Liver Fibrosis Test: Data from Three Cohorts of Patients with Metabolic Dysfunction-associated Steatotic Liver Disease. (2025/12/26) ♡
• Diagnostic dilemma of cystic biliary atresia: A series of two cases and brief review of the diagnostic modalities. (2025/12/26) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Phenotypic Screening Coupled with AI-Driven Target Deconvolution Identifies α-Terthienyl as a Dual DPP-IV/HSD17β13 Modulator with Efficacy in a Mouse Model of MASLD. (2025/12/25) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Effect of standard versus long alimentary limb distal Roux-en-Y gastric bypass on weight loss and nutritional outcomes at 10 years in patients with BMI 50-60 kg/m2-a secondary analysis of a randomized clinical trial. (2025/12/24) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Mapping research landscapes: a bibliometric and visual analysis of ketogenic diet interventions in liver health (2013-2024). (2025/12/23) ♡
• Global Trends in Alcohol Control Policies Between 2010-2019. (2025/12/23) ♡
• Loss, amplification or mistiming of the daily rhythms of metabolic markers in patients with cirrhosis. (2025/12/23) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Severe Hyponatremia as a Marker of Malignancy in Patients with Liver Cirrhosis. Clinical Implications and Prognostic Relevance in Two Cases]. (2025/12/23) ♡
• Patient-, Provider-, and Area-Level Factors Associated with Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis in North Carolina. (2025/12/23) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Gluten's silent strike: Unmasking its impact on liver health. (2025/12/22) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Agrimonia pilosa Extract Alleviates CDAHFD-Induced Non-Alcoholic Steatohepatitis and Fibrosis in Mice. (2025/12/22) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Comparative Evaluation of the Effects of Oral Anti-hyperglycemic Agents and an Ayurvedic Hepatoprotective Agent in a Rat Model of Non-alcoholic Fatty Liver Disease (NAFLD). (2025/12/22) ♡
• "Noninvasive predictive marker for esophageal variceal bleeding". (2025/12/18) ♡
• NUP85 siRNA loaded red blood cell-derived extracellular vesicles alleviate hepatic steatosis in MASLD. (2025/12/18) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. HCC in the Era of Emerging MASH: The Role of Ultrasound in Surveillance and New Sonographic Features in Diagnosis. (2025/12/18) ♡
• Exploring Herbal and Indian Traditional Remedies in the Management of Non-Alcoholic Fatty Liver Disease: Recent Advances and Clinical Trial Insights. (2025/12/16) ♡
• A commentary on "Intrinsic capacity, genetic susceptibility, and the risks of metabolic dysfunction-associated steatotic liver disease and cirrhosis". (2025/12/16) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Gut microbiota in hepatic encephalopathy: a 3PM-guided three-tier health strategy. (2025/12/16) ♡
• Textbook outcomes after splenectomy in patients with portal hypertension. (2025/12/15) ♡
• Sleep patterns, genetic factors and the risk of cirrhosis: a prospective cohort study. (2025/12/15) ♡
• Real-Life Challenges in Assessing Nutritional Status and Quality of Life in Patients with Cirrhosis. (2025/12/15) ♡
• Assessment of chronic liver disease using shear wave elastography: Correlation with serum markers. (2025/12/15) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. The effect of a diet based on vegetable and dairy protein on biochemical and functional indicators of sarcopenia in patients with liver cirrhosis: a randomized controlled trial. (2025/12/13) ♡
• Malnutrition Is Associated with Increased Liver Stiffness in Type 2 Diabetes: The Mediating Role of Inflammation. (2025/12/13) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Getting to Implementation: applying data-driven implementation strategies to improve guideline concordant surveillance for hepatocellular carcinoma. (2025/12/12) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.